Skip to content
Inciteful Med

Understanding a Cartilage-Hair Hypoplasia (CHH) Diagnosis

Last updated:

Cartilage-Hair Hypoplasia (CHH) is a rare genetic disorder caused by RMRP gene mutations, resulting in short stature, sparse hair, and immune system challenges. It is often detected via newborn screening. Parents should consult an immunologist before giving their child live vaccines.

Key Takeaways

  • • CHH is a rare genetic condition characterized by short stature, sparse hair, and variable immune system weakness.
  • • The condition is caused by inheriting two mutated copies of the RMRP gene, often with no prior family history.
  • • Newborn screening using the TREC assay often provides the first sign of CHH, which is then confirmed by genetic testing.
  • • Children with CHH should avoid live viral vaccines until their immune system is evaluated by a pediatric immunologist.
  • • Parents should monitor newborns for signs of Hirschsprung disease, such as severe constipation or a swollen belly.

Receiving a diagnosis of Cartilage-Hair Hypoplasia (CHH) can feel overwhelming, but it is a well-studied condition with a clear genetic cause [1]. CHH is a rare genetic disorder that primarily affects bone growth, hair characteristics, and the immune system [1]. While the name describes the most visible features—short stature and sparse hair—the condition is a “spectrum,” meaning it affects every child differently [2].

Understanding the Core Features

CHH is characterized by three main clinical pillars:

  • Skeletal Dysplasia: This refers to abnormal bone development, specifically metaphyseal chondrodysplasia (changes in the growth plates near the ends of long bones) [3]. This typically results in disproportionate short stature, where the limbs are shorter in relation to the torso [1].
  • Hypotrichosis: This is the medical term for fine, sparse, and light-colored hair [3]. This occurs because the core of the hair shaft is often missing or underdeveloped.
  • Immune Variability: The immune system’s ability to fight infections can range from completely normal to severely weakened [4].

Why Did This Happen?

CHH is caused by mutations in a specific gene called RMRP [5]. It follows an autosomal recessive inheritance pattern, meaning a child must inherit one changed copy of the gene from each parent to have the condition [6]. Both parents are typically asymptomatic “carriers” of the mutation, which is why there was likely no prior family history of the disease [2].

While rare globally, CHH is more common in certain populations due to a “founder effect,” where a specific genetic mutation is passed down through generations in a community [5]:

  • Old Order Amish: A high prevalence is seen due to common variants [2].
  • Finnish Descent: A high prevalence is also seen in this population [2].

How CHH is Detected and Confirmed

For many families, the first sign of CHH appears on a Newborn Screening through a test called the TREC assay [7].

  • The TREC Assay: This test measures small circles of DNA (TRECs) produced when the body makes new T-cells (infection-fighting white blood cells) [7].
    • Absent TRECs: A result of “zero” or absent TRECs often points to a more severe immune phenotype, sometimes reaching the level of Severe Combined Immunodeficiency (SCID) [8].
    • Decreased TRECs: This may indicate a milder immune challenge, though it still requires close monitoring [7].
  • Genetic Confirmation: While screening provides a hint, the diagnosis is confirmed by sequencing the RMRP gene to identify the specific mutations [3].

Immediate Considerations for Parents

Stabilizing your child’s health starts with understanding their specific risks.

  1. Immune Protection: Because many children with CHH have weakened immune systems, they may be at higher risk for severe infections [4]. For more on managing this, see Treatment Strategies for Cartilage-Hair Hypoplasia.
  2. Vaccine Safety: Live viral vaccines (such as the rotavirus vaccine given to infants) are generally avoided in children with confirmed or suspected immune deficiencies until cleared by an immunologist [9].
  3. Digestive Health: Some infants with CHH may have Hirschsprung disease, a condition affecting the large intestine that can cause severe constipation [10]. Symptoms include a failure to pass meconium in the first 48 hours of life or a swollen belly [4].

To dive deeper into this condition and build a comprehensive plan for your child, explore the following pages:

Frequently Asked Questions

How is Cartilage-Hair Hypoplasia diagnosed?
CHH is often first detected through newborn screening using the TREC assay, which measures immune function. The diagnosis is then officially confirmed by genetically sequencing the RMRP gene to identify specific mutations.
What causes Cartilage-Hair Hypoplasia?
CHH is caused by mutations in the RMRP gene. It is an autosomal recessive condition, meaning a child must inherit one mutated copy of the gene from each parent, who are usually healthy carriers.
What are the main signs of Cartilage-Hair Hypoplasia?
The core features include disproportionate short stature due to abnormal bone growth, fine and sparse light-colored hair, and a highly variable immune system that may struggle to fight infections.
Are live vaccines safe for a child with CHH?
Live viral vaccines, such as the rotavirus vaccine, should generally be avoided in children with suspected or confirmed CHH. They should only be administered after the child is evaluated and cleared by a pediatric immunologist.
Does CHH cause digestive issues in babies?
Yes, some infants with CHH may also have Hirschsprung disease, a condition affecting the large intestine. Symptoms include severe constipation, a swollen belly, or a failure to pass meconium in the first 48 hours of life.

Questions for Your Doctor

  • • Based on my child's TREC levels, how would you categorize their immune risk (absent, decreased, or normal)?
  • • Does my child need immediate specialized care from a pediatric immunologist or a genetics team?
  • • Are there specific symptoms of Hirschsprung disease we should be watching for right now?
  • • Is it safe for my child to receive live vaccines, like the rotavirus vaccine, at this time?
  • • What schedule of follow-up scans or blood tests do you recommend to monitor their bone growth and immune health?

Questions for You

  • • What were the specific results of the newborn screening, and have we received a copy of the genetic test report?
  • • Have I noticed any patterns in my child's digestion, such as frequent constipation, failure to pass meconium early on, or discomfort after feeding?
  • • Who are the key specialists we need to add to our child's care team right away?
  • • What are our family's immediate priorities for our child's comfort and development?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Neonatal erythroderma and immunodysplasia: Overlap of cartilage-hair hypoplasia and Omenn syndrome.

    Insalaco A, Rossi C, Bertucci E, et al.

    European journal of medical genetics 2026; (80()):105069 doi:10.1016/j.ejmg.2026.105069.

    PMID: 41616907
  2. 2

    RMRP-related short stature: A report of six additional Japanese individuals with cartilage hair hypoplasia and literature review.

    Uchida N, Ishii T, Nishimura G, et al.

    American journal of medical genetics. Part A 2024; (194(6)):e63562 doi:10.1002/ajmg.a.63562.

    PMID: 38337186
  3. 3

    Cartilage-hair hypoplasia-anauxetic dysplasia spectrum disorders harboring RMRP mutations in two Korean children: A case report.

    Park JH, Im M, Kim YJ, et al.

    Medicine 2024; (103(21)):e37247 doi:10.1097/MD.0000000000037247.

    PMID: 38787970
  4. 4

    Immunodeficiency in cartilage-hair hypoplasia: Pathogenesis, clinical course and management.

    Vakkilainen S, Taskinen M, Mäkitie O

    Scandinavian journal of immunology 2020; (92(4)):e12913 doi:10.1111/sji.12913.

    PMID: 32506568
  5. 5

    Identification of a founder effect involving n.197C>T variant in RMRP gene associated to cartilage-hair hypoplasia syndrome in Brazilian patients.

    Gomes ME, Kehdy F, de Neves-Manta FS, et al.

    Scientific reports 2024; (14(1)):13436 doi:10.1038/s41598-024-64407-8.

    PMID: 38862721
  6. 6

    Familial cartilage-hair hypoplasia: prenatal ultrasound features and clinical outcomes in three siblings with identical RMRP variants.

    Portela Carvalho C, Martins A, Alves I, Guedes-Martins L

    BMJ case reports 2026; (19(2)) doi:10.1136/bcr-2025-267490.

    PMID: 41720498
  7. 7

    Abnormal Newborn Screening Follow-up for Severe Combined Immunodeficiency in an Amish Cohort with Cartilage-Hair Hypoplasia.

    Scott EM, Chandra S, Li J, et al.

    Journal of clinical immunology 2020; (40(2)):321-328 doi:10.1007/s10875-019-00739-9.

    PMID: 31903518
  8. 8

    Shorter birth length and decreased T-cell production and function predict severe infections in children with non-severe combined immunodeficiency cartilage-hair hypoplasia.

    Pello E, Kainulainen L, Vakkilainen M, et al.

    The journal of allergy and clinical immunology. Global 2024; (3(1)):100190 doi:10.1016/j.jacig.2023.100190.

    PMID: 38187867
  9. 9

    The Safety and Efficacy of Live Viral Vaccines in Patients With Cartilage-Hair Hypoplasia.

    Vakkilainen S, Kleino I, Honkanen J, et al.

    Frontiers in immunology 2020; (11()):2020 doi:10.3389/fimmu.2020.02020.

    PMID: 32849667
  10. 10

    Immunologic Heterogeneity in 2 Cartilage-Hair Hypoplasia Patients With a Distinct Clinical Course.

    Gamliel A, Lee YN, Lev A, et al.

    Journal of investigational allergology & clinical immunology 2023; (33(4)):263-270 doi:10.18176/jiaci.0792.

    PMID: 35166674

This page provides educational information about Cartilage-Hair Hypoplasia (CHH). It is not a substitute for professional medical advice, diagnosis, or treatment from your child's pediatrician or geneticist.

Stay up to date

Get notified when new research about Cartilage-hair hypoplasia is published.

No spam. Unsubscribe anytime.